2020
DOI: 10.3390/molecules25071508
|View full text |Cite
|
Sign up to set email alerts
|

Tumor Targeted Nanocarriers for Immunotherapy

Abstract: The paramount discovery of passive accumulation of nanoparticles in tumoral tissues triggered the development of a wide number of different nanoparticles capable of transporting therapeutic agents to tumoral tissues in a controlled and selective way. These nanocarriers have been endowed with important capacities such as stimuli-responsive properties, targeting abilities, or the capacity to be monitored by imaging techniques. However, after decades of intense research efforts, only a few nanomedicines have reac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
17
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 99 publications
0
17
0
Order By: Relevance
“…Increasing evidence has pinpointed TME as the major target of nanomedicine. NPs have the potential to interact with the TME in unexpected ways and to ultimately and critically affect performance and tumor response [ 108 , 109 ]. A wide range of NPs with different physicochemical characteristics has been developed to stimulate the immune system and battle cancer [ 66 , 110 ].…”
Section: Possible Implications In Cancer Nano-immunotherapymentioning
confidence: 99%
See 1 more Smart Citation
“…Increasing evidence has pinpointed TME as the major target of nanomedicine. NPs have the potential to interact with the TME in unexpected ways and to ultimately and critically affect performance and tumor response [ 108 , 109 ]. A wide range of NPs with different physicochemical characteristics has been developed to stimulate the immune system and battle cancer [ 66 , 110 ].…”
Section: Possible Implications In Cancer Nano-immunotherapymentioning
confidence: 99%
“…For example, the N-glycan containing terminal β-galactose can be recognized by galectins, a class of endogenous lectin that bind specially to β-galactoside sugars, modulating the macrophages functions [ 123 ]. Given this, several attempts are underway to develop therapies to foster TAMs polarization into cancer-suppressive phenotypes, such as sugar agonists or antagonist treatments and nanoparticles-based approaches [ 109 , 124 ].…”
Section: Possible Implications In Cancer Nano-immunotherapymentioning
confidence: 99%
“…Given their abundance, their regulatory function, and their specific phagocytic capacity, TAMs represent excellent cellular targets for nanoparticular delivery. Recent evidence suggests that nanoparticles can be directed to tumor-resident TAMs and, depending on the nanoparticular formulation, be utilized to deplete or repolarize M2 TAMs ( Figure 2 C) [ 82 , 100 ]. First preclinical data in mouse tumor models combining nanoparticular M2 targeting with immunotherapy provide grounds for optimism.…”
Section: Nano-sensitizing the Tumor Microenvironment (Tme)mentioning
confidence: 99%
“…Nanomedicine puts forward a multitude of conceptual tools to tackle cancer cells directly and/or to improve the delivery of therapeutic moieties, such as drugs, small interfering RNA (siRNA), antibodies, etc. [ 7 , 8 , 9 , 10 , 11 ]. Among these, nanoparticles able to convey different therapeutic cargos and with unique physico-chemical properties have allowed the design of novel combinatory strategies to tackle cancer [ 7 , 8 , 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…[ 7 , 8 , 9 , 10 , 11 ]. Among these, nanoparticles able to convey different therapeutic cargos and with unique physico-chemical properties have allowed the design of novel combinatory strategies to tackle cancer [ 7 , 8 , 9 , 10 , 11 ]. Gold nanoparticles (AuNPs) possess remarkable optical properties that depend on their easy tunable size and shape and a large surface area to volume ratio, optimal for ease of functionalization with different agents [ 12 ].…”
Section: Introductionmentioning
confidence: 99%